ARX vs EYE

ASX Healthcare sector comparison — updated 3 Sep 2026 — Healthcare sector

ARX

AROA BIO FPO [ARX]

56MEDIUM

EYE

NOVA EYE FPO [EYE]

58MEDIUM

Score Breakdown

ARX EYE
Technical
48
46
Catalyst
55
54
Sentiment
50
50
Fundamental
99
60
Momentum
46
65
Risk Gate
50
50

Key Metrics

ARX Metric EYE
$191.1MMarket Cap$38.5M
144KAvg Volume (20d)199K
N/AShort InterestN/A
$0.80052-Week High$0.205
$0.49552-Week Low$0.100
+0.0%Daily Change+3.8%
$0.540Reference Price$0.135
+4.9%ROE-26.1%
+4.5%Profit Margin-12.4%

Active Signals

ARX Signals

RSI drifting toward oversold territory — worth watching
MACD momentum is losing steam
Stochastic is deep in oversold territory — bounce conditions forming
Trading below both moving averages — the trend is working against this one
Sitting near support — this level has held before and could attract buyers again
Drifting lower — down 4.4% over the last 5 days
Volume-price trend says buyers are quietly accumulating — price hasn't caught up yet
Below the 200-day average — the long-term trend is still working against it

EYE Signals

Stochastic just turned bullish from a low level — early reversal sign
Lagging the Small Ords index — relative strength of 0.89, underperforming its peers
Below the 200-day average — the long-term trend is still working against it
Critical cash runway (1.2 quarters)
Low P/S ratio (1.1x)
Moderate revenue growth (+11%)
EPS estimates revised upward (+10pts)
Small-cap ($20-100M)

Ask Scout AI to compare ARX and EYE in depth.

Open Scout AI →

Track both stocks and 2,200+ more — Free

Daily AI-powered screening across every ASX small cap.

Open Screener

Related Comparisons

ATH vs ATX →ATH vs BLS →ATH vs LDX →ATH vs SPL →ATX vs EYE →
ARX Full Analysis → EYE Full Analysis → Healthcare Sector → All Comparisons →
GENERAL INFORMATION ONLY. SmallCapData provides algorithmic screening data and does not constitute personal financial advice, a recommendation, or an offer to buy or sell any security. This content is produced by an algorithm, not a licensed financial adviser. You should consider seeking independent financial advice before making any investment decision. Past performance is not indicative of future results. Trading in small-cap securities carries a high degree of risk, including the risk of total loss of capital. The author may hold positions in mentioned securities. SmallCapData does not hold an Australian Financial Services Licence (AFSL).